科部介紹

DEPARTMENTS & CENTERS

醫師xx

語言

專長

現職

  • 新北市立土城醫院心臟內科副教授級主治醫師

學歷

  • 長庚大學臨床研究所博士班進修
  • 長庚大學中西醫雙主修學士

經歷

  • 林口長庚心臟內一科主治醫師
  • 林口長庚心臟內一科住院醫師
  • 林口長庚內科部住院醫師

學會與認證

  • 中華民國內科專科醫師
  • 台灣介入性心臟血管醫學會會員
  • 中華民國心臟學會心臟血管介入專科醫師
  • 中華民國心臟學會專科醫師

論文及期刊發表

  • 僅列以第一作者或通訊作者身份所發表的文章

  • Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor
    Cardiovasc Diabetol. 2020;19:160
    Lee HF,et al.
  • Direct Oral Anticoagulants in Atrial Fibrillation Patients with Concomitant Hyperthyroidism.
    J Clin Endocrinol Metab. 2020.
    Lee HF
  • Oral Anticoagulants and Antiplatelet Agents in Patients With Atrial Fibrillation and Concomitant Critical Limb Ischemia: A Nationwide Cohort Study.
    Can J Cardiol. 2020
    Lee HF,et al.
  • Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Atrial Fibrillation Patients with Concomitant Peripheral Artery Disease
    Eur Heart J Cardiovasc Pharmacother. 2019.
    Lee HF,et al.
  • Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation
    Chest. 2019 May 16. pii: S0012-3692(19)31056-6. doi: 10.1016/j.chest.2019.04.108
    Chan YH, Lee HF(co-first author),et al.
  • Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation.J Am Heart Assoc
    2019 Mar 5;8(5):e011112. doi: 10.1161/JAHA.118.011112
    Lee HF,et al.
  • End Stage Renal Disease Patients Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers May Reduce the Risk of Mortality: A Taiwanese Nationwide Cohort Study
    Intern Med J. 2018 May 29. doi: 10.1111/imj.13971.
    Lee HF, et al.
  • The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillation.
    Int J Cardiol. 2018 Jun 15;261:78-83. doi: 10.1016/j.ijcard.2018.03.063.
    Lee HF, et al.
  • Response to Letter to the Editor
    J Formos Med Assoc. 2018 May;117(5):456. doi: 10.1016/j.jfma.2017.12.003. Epub 2018 Feb 13.
    Lee HF, et al
  • Crusade Microcatheter-Facilitated Reverse Wire Technique for Revascularization of Bifurcation Lesions of Coronary Arteries.
    Acta Cardiol Sin. 2018 Jan;34(1):31-36
    Lee HF, et al.
  • Low bone mineral density may be associated with long-term risk of cancer in the middle-aged population: A retrospective observational study from a single center.
    J Formos Med Assoc. 2018 Apr;117(4):339-345. doi: 10.1016/j.jfma.2017.04.021
    Lee HF, et al
  • Impact of Chronic Kidney Disease on Long -term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention.
    Korean Circ J. 2017 Jan;47(1):50-55. doi: 10.4070/kcj.2016.0093.
    Peng JR, Chang CJ, Wang CL, Tung YC, Lee HF(通訊作者)..
  • Using Rivaroxaban as Thrombolytic Treatment for a Patient of Pedal Arch Arterial Thrombosis with Suboptimal Result of Endovascular Therapy.
    Acta Cardiol Sin. 2016 Sep;32(5):623-626.
    Lee HF*, et al.
  • Dialysis Patients with Implanted Drug-Eluting Stents Have Lower Major Cardiac Events and Mortality than Those with Implanted Bare-Metal Stents: A Taiwanese Nationwide Cohort Study.
    PLoS One. 2016 Jan 5;11(1):e0146343. doi: 10.1371/journal.pone.0146343.
    Lee HF, et al.
  • Prognostic significance of dilated inferior vena cava in advanced decompensated heart failure.
    Int J Cardiovasc Imaging. 2014 Oct;30(7):1289-95. doi: 10.1007/s10554-014-0468-y.
    Lee HF, et al.
  • Prognostic value of global left ventricular strain for conservatively treated patients with symptomatic aortic stenosis.
    J Cardiol. 2013;62:301-6.
    Lee HF, et al.
  • Association of blood group A with coronary artery disease in young adults in Taiwan.
    Intern Med. 2012;51:1815-20
    Lee HF,et al.